ImageneBio (IMA) Net Margin Growth (1y) (2021 - 2024)
ImageneBio (IMA) Net Margin Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | -392.00 |
| 10 | ImageneBio | 47.00 Mn | -88.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 128,694.00 |
| Dec 31, 2023 | -269,091.00 |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 56.04 Mn |
| Mar 31, 2023 | 39,939.00 |
| Dec 31, 2022 | -14,027.00 |
| Sep 30, 2022 | -1.51 Mn |
| Jun 30, 2022 | -55.97 Mn |
| Mar 31, 2022 | 283,039.00 |
| Dec 31, 2021 | 4.83 Mn |
| Sep 30, 2021 | -109,793.00 |
| Jun 30, 2021 | -136,115.00 |
| Mar 31, 2021 | -327,504.00 |